- Home
- COMM vs ARQT Comparison
COMM vs ARQT Comparison
Compare COMM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- ARQT
- Stock Information
- Founded
- COMM 1976
- ARQT 2016
- Country
- COMM United States
- ARQT United States
- Employees
- COMM N/A
- ARQT N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- COMM Technology
- ARQT Health Care
- Exchange
- COMM Nasdaq
- ARQT Nasdaq
- Market Cap
- COMM 1.2B
- ARQT 1.1B
- IPO Year
- COMM 2013
- ARQT 2020
- Fundamental
- Price
- COMM $5.02
- ARQT $13.08
- Analyst Decision
- COMM Hold
- ARQT Strong Buy
- Analyst Count
- COMM 5
- ARQT 5
- Target Price
- COMM $3.00
- ARQT $17.00
- AVG Volume (30 Days)
- COMM 4.3M
- ARQT 1.9M
- Earning Date
- COMM 02-26-2025
- ARQT 02-25-2025
- Dividend Yield
- COMM N/A
- ARQT N/A
- EPS Growth
- COMM N/A
- ARQT N/A
- EPS
- COMM N/A
- ARQT N/A
- Revenue
- COMM $5,183,800,000.00
- ARQT $138,708,000.00
- Revenue This Year
- COMM N/A
- ARQT $215.24
- Revenue Next Year
- COMM N/A
- ARQT $53.63
- P/E Ratio
- COMM N/A
- ARQT N/A
- Revenue Growth
- COMM 21.78
- ARQT 182.84
- 52 Week Low
- COMM $0.86
- ARQT $5.38
- 52 Week High
- COMM $7.19
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- COMM 44.61
- ARQT 41.94
- Support Level
- COMM $4.49
- ARQT $13.33
- Resistance Level
- COMM $5.15
- ARQT $15.09
- Average True Range (ATR)
- COMM 0.34
- ARQT 0.86
- MACD
- COMM -0.05
- ARQT -0.16
- Stochastic Oscillator
- COMM 34.93
- ARQT 6.25
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. They have operating segments, which excludes our Home segment: Connectivity and Cable Solutions (CCS), Outdoor Wireless Networks (OWN), Networking, Intelligent Cellular and Security Solutions (NICS) and Access Network Solutions (ANS).
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.